Brief: Natco Pharma Announces Launch Of Additional Strengths For Generic Version Of Revlimid In Usa
10/03/2023 02:39
March 10 (Reuters) - Natco Pharma Ltd NATP.NS :
* NATCO ANNOUNCES LAUNCH OF ADDITIONAL STRENGTHS FOR GENERIC VERSION OF
REVLIMID
(LENALIDOMIDE CAPSULES), IN USA
Source text for Eikon: ID:nBSEdsyYX
Further company coverage: NATP.NS
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Natco Pharma
See all newsBrief: Natco Pharma Launches Carboplatin Injection In Us With Teyro Labs
India's Natco Pharma jumps after launching ovarian cancer drug in US
Brief: Natco Pharma Announces Launch Of Carboplatin Injection In The U.S. Market
Brief: Natco Pharma To Increase Its Investment In Egenesis To $16.70 Million
Brief: Natco Pharma Approves Rights Issue Up To 12.79 Billion Rupees